School of Population Health and Environmental Sciences, King's College London; National Cancer Registration and Analysis Service, Public Health England, London.
School of Population Health and Environmental Sciences, King's College London, London.
Br J Gen Pract. 2021 Oct 28;71(712):e826-e835. doi: 10.3399/BJGP.2020.1030. Print 2021 Nov.
There is substantial variation in the use of urgent suspected cancer referral (2-week wait [2WW]) between practices.
To examine the change in use of 2WW referrals in England over 10 years (2009/2010 to 2018/2019) and the practice and population factors associated with cancer detection.
Retrospective cross-sectional study of English general practices and their 2WW referral and Cancer Waiting Times database detection data (all cancers other than non-melanoma skin cancers) from 2009/2010 to 2018/2019.
A retrospective study conducted using descriptive statistics of changes over 10 years in 2WW referral data. Yearly linear regression models were used to determine the association between cancer detection rates and quintiles of practice and population characteristics. Predicted cancer detection rates were calculated, as well as the difference between lowest to highest quintiles.
Over the 10 years studied there were 14.89 million 2WW referrals (2.24 million in 2018/2019), and 2.68 million new cancer diagnoses, of which 1.26 million were detected following 2WW. The detection rate increased from 41% to 52% over the time period. In 2018/2019 an additional 66 172 cancers were detected via 2WW compared with 2009/2010. Higher cancer detection via 2WW referrals was associated with larger practices and those with younger GPs. From 2016/2017 onwards more deprived practice populations were associated with decreased cancer detection.
From 2009/2010 to 2018/2019 2WW referrals increased on average by 10% year on year. The most consistent association with higher cancer detection was found for larger practices and those with younger GPs, though these differences became attenuated over time. The more recent association between increased practice deprivation and lower cancer detection is a cause for concern. The COVID-19 pandemic has led to significant impacts on 2WW referral activity and the impact on patient outcomes will need to be studied.
实践中对紧急疑似癌症转诊(2 周等待[2WW])的使用存在很大差异。
检查英格兰在 10 年内(2009/2010 年至 2018/2019 年)使用 2WW 转诊的变化情况,以及与癌症检出率相关的实践和人群因素。
对 2009/2010 年至 2018/2019 年期间英国普通诊所及其 2WW 转诊和癌症等待时间数据库检出数据(非黑素瘤皮肤癌除外的所有癌症)进行回顾性横断面研究。
使用 10 年期间 2WW 转诊数据变化的描述性统计进行回顾性研究。使用年度线性回归模型确定癌症检出率与实践和人群特征五分位数之间的关联。计算了预测的癌症检出率,以及最低到最高五分位数之间的差异。
在所研究的 10 年内,共进行了 1489 万次 2WW 转诊(2018/2019 年为 224 万次),新诊断出 2680 万例癌症,其中 1260 万例是通过 2WW 检出的。在此期间,检出率从 41%增加到 52%。与 2009/2010 年相比,2018/2019 年通过 2WW 额外检出了 66172 例癌症。通过 2WW 转诊检测到的癌症比例更高与规模较大的实践以及年轻的全科医生有关。自 2016/2017 年以来,更贫困的实践人群与癌症检出率下降有关。
从 2009/2010 年到 2018/2019 年,2WW 转诊平均每年增加 10%。与更高癌症检出率最一致的关联是规模较大的实践和年轻的全科医生,尽管这些差异随着时间的推移而减弱。最近与实践贫困程度增加和癌症检出率降低之间的关联令人担忧。COVID-19 大流行对 2WW 转诊活动产生了重大影响,需要研究其对患者结局的影响。